Hikma Pharmaceutical | HIK - Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Almirall EUR 517.4M 32K 2025-12
argenx SE USD 904M 10.57M 2026-03
AstraZeneca USD 8.18B 4.35B 2026-03
Autolus Therapeutics Ltd USD 85.73M 11.02M 2026-03
Bayer EUR 9.88B 452M 2026-03
Fresenius EUR 5.25B 337M 2025-12
Genmab DKK 798M 235M 2025-12
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
GRIFOLS EUR 1.45B 255.28M 2026-03
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Lakefront Biotherapeutics EUR 70.18M 50.08M 2026-03
Lonza CHF 2.9B 184M 2025-06
Merck EUR 4.09B 687M 2026-03
Orion EUR 302.9M 64.2M 2026-03
Recordati EUR 482.31M 98.3M 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 9.31B 1.2B 2026-03
UCB EUR 2.96B 196M 2025-12